
Kazuo Fujihara
Professor, Department of Multiple Sclerosis Therapeutics, Fukushima Medical University School of Medicine.
Kazuo Fujihara, M.D. is Professor, Department of Multiple Sclerosis Therapeutics, Fukushima Medical University School of Medicine, and Director, Multiple Sclerosis & Neuromyelitis Optica Center, Southern TOHOKU Research Institute for Neuroscience (STRINS), Koriyama, Japan. Dr. Fujihara is a neurologist and has mainly worked in the field of multiple sclerosis (MS), neuromyelitis optica (NMO) and related neuroimmunological disorders.
He has been a member of the International Panel on Diagnosis of MS (the 2010 and 2017 revisions to the McDonald Criteria), the International Panel on NMO Diagnosis (the 2015 and 2025 International Consensus Diagnostic Criteria of NMOSD), the International Panel on Diagnosis of MOGAD (2020~2023), the International Multiple Sclerosis Differential Diagnosis Consortium of Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) [Co-chair of the Working Group on MS Differential Diagnosis in Global Populations] (2021~2024) and the International Advisory Committee on Clinical Trials in MS (2022~2025).
He has served on the Executive Committee, International Medical and Scientific Board of The Multiple Sclerosis International Federation (MSIF) (2013~2024), and the Board of European Charcot Foundation (ECF) (2013~). He is an inaugural member and President Emeritus (2025~) of Pan-Asian Committee for Treatment and Research in Multiple Sclerosis (PACTRIMS), and Immediate Past President (2022~) of Japanese Society for Neuroimmunology (JSNI).